Supplementary Table 1 from Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study

2026 Open access

Read full text
Authors: Melissa Alsina, Nina Shah, Sundar Jagannath, Jonathan L. Kaufman, David Siegel, Nikhil C. Munshi, Jacalyn M. Rosenblatt, Yi Lin, Andrzej J. Jakubowiak, Benjamin Avi Derman, Aojun Li, Pingping Mao
+9 more Maeva Fincker, Ashish Yeri, Nathan Martin, Timothy Campbell, Olivia C. Finney, Anna Truppel-Hartmann, Fabio Petrocca, Jesús G. Berdeja, Noopur S Raje
DOI: 10.1158/2326-6066.31923796
Cited by: 1

Abstract

Anti-human antibodies used in the cytometry by time-of-flight analysis

Fields of Study & Subjects

CAR-T cell therapy research Immunotherapy and Immune Responses Multiple Myeloma Research and Treatments

Publication details

Publisher
American Association for Cancer Research (AACR)
Publication date
2 April 2026